He is recognised as one of the leaders in Angioplasty in the country and is proficient in a lot of new devices and technologies.
Dr. Grüntzig presented the results of his first four angioplasty cases at the 1977 American Heart Association (AHA) meeting, which led to widespread acknowledgement of his pioneering work.
Glycoprotein IIb/IIIa inhibitors are frequently used during percutaneous coronary intervention (angioplasty with or without intracoronary stent placement).
Primary angioplasty and stenting for Carotid artery and Vertebral artery and the basilar arteries can be performed to open up blocked arteries.
Early leaders of the field included Russian surgeon Nikolai Korotkov, noted for developing early surgical techniques, American interventional radiologist Charles Theodore Dotter who is credited with inventing minimally invasive angioplasty, and Australian Robert Paton, who helped the field achieve recognition as a specialty.